GLP-1 Agonist and Cardiovascular Complications

Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KNUDSEN LISELOTTE BJERRE, NIELSEN LARS BO, ELBROND BODIL, ROLIN BIDDA CHARLOTTE, SELMER JOHAN, CARR RICHARD DAVID, LARSEN JENS, CHRISTOFFERSEN CHRISTINA
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KNUDSEN LISELOTTE BJERRE
NIELSEN LARS BO
ELBROND BODIL
ROLIN BIDDA CHARLOTTE
SELMER JOHAN
CARR RICHARD DAVID
LARSEN JENS
CHRISTOFFERSEN CHRISTINA
description Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2013338071A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2013338071A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2013338071A13</originalsourceid><addsrcrecordid>eNrjZNBz9wnQNVRwTM_PyywuUUjMS1FwTixKycwvSyxOLs1JLFJwzs8tyMlMTizJzM8r5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGxsbGFgbmho6GxsSpAgBCFCrS</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLP-1 Agonist and Cardiovascular Complications</title><source>esp@cenet</source><creator>KNUDSEN LISELOTTE BJERRE ; NIELSEN LARS BO ; ELBROND BODIL ; ROLIN BIDDA CHARLOTTE ; SELMER JOHAN ; CARR RICHARD DAVID ; LARSEN JENS ; CHRISTOFFERSEN CHRISTINA</creator><creatorcontrib>KNUDSEN LISELOTTE BJERRE ; NIELSEN LARS BO ; ELBROND BODIL ; ROLIN BIDDA CHARLOTTE ; SELMER JOHAN ; CARR RICHARD DAVID ; LARSEN JENS ; CHRISTOFFERSEN CHRISTINA</creatorcontrib><description>Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20131219&amp;DB=EPODOC&amp;CC=US&amp;NR=2013338071A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20131219&amp;DB=EPODOC&amp;CC=US&amp;NR=2013338071A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KNUDSEN LISELOTTE BJERRE</creatorcontrib><creatorcontrib>NIELSEN LARS BO</creatorcontrib><creatorcontrib>ELBROND BODIL</creatorcontrib><creatorcontrib>ROLIN BIDDA CHARLOTTE</creatorcontrib><creatorcontrib>SELMER JOHAN</creatorcontrib><creatorcontrib>CARR RICHARD DAVID</creatorcontrib><creatorcontrib>LARSEN JENS</creatorcontrib><creatorcontrib>CHRISTOFFERSEN CHRISTINA</creatorcontrib><title>GLP-1 Agonist and Cardiovascular Complications</title><description>Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBz9wnQNVRwTM_PyywuUUjMS1FwTixKycwvSyxOLs1JLFJwzs8tyMlMTizJzM8r5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGxsbGFgbmho6GxsSpAgBCFCrS</recordid><startdate>20131219</startdate><enddate>20131219</enddate><creator>KNUDSEN LISELOTTE BJERRE</creator><creator>NIELSEN LARS BO</creator><creator>ELBROND BODIL</creator><creator>ROLIN BIDDA CHARLOTTE</creator><creator>SELMER JOHAN</creator><creator>CARR RICHARD DAVID</creator><creator>LARSEN JENS</creator><creator>CHRISTOFFERSEN CHRISTINA</creator><scope>EVB</scope></search><sort><creationdate>20131219</creationdate><title>GLP-1 Agonist and Cardiovascular Complications</title><author>KNUDSEN LISELOTTE BJERRE ; NIELSEN LARS BO ; ELBROND BODIL ; ROLIN BIDDA CHARLOTTE ; SELMER JOHAN ; CARR RICHARD DAVID ; LARSEN JENS ; CHRISTOFFERSEN CHRISTINA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2013338071A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KNUDSEN LISELOTTE BJERRE</creatorcontrib><creatorcontrib>NIELSEN LARS BO</creatorcontrib><creatorcontrib>ELBROND BODIL</creatorcontrib><creatorcontrib>ROLIN BIDDA CHARLOTTE</creatorcontrib><creatorcontrib>SELMER JOHAN</creatorcontrib><creatorcontrib>CARR RICHARD DAVID</creatorcontrib><creatorcontrib>LARSEN JENS</creatorcontrib><creatorcontrib>CHRISTOFFERSEN CHRISTINA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KNUDSEN LISELOTTE BJERRE</au><au>NIELSEN LARS BO</au><au>ELBROND BODIL</au><au>ROLIN BIDDA CHARLOTTE</au><au>SELMER JOHAN</au><au>CARR RICHARD DAVID</au><au>LARSEN JENS</au><au>CHRISTOFFERSEN CHRISTINA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLP-1 Agonist and Cardiovascular Complications</title><date>2013-12-19</date><risdate>2013</risdate><abstract>Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2013338071A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title GLP-1 Agonist and Cardiovascular Complications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T08%3A45%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KNUDSEN%20LISELOTTE%20BJERRE&rft.date=2013-12-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2013338071A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true